Acquired dysfibrinogenemia in a hemophiliac with hepatoma: Resolution of fibrinogen dysfunction following chemotherapy

Keyphrases

• Fibrinogen 100%
• Chemotherapy 100%
• Hemophiliacs 100%
• Hypofibrinogenemia 100%
• Hepatoblastoma 100%
• Fibrin Monomer 60%
• Gel Electrophoresis 20%
• Sepsis 20%
• Thrombin 20%
• Wound Healing 20%
• Acid Content 20%
• Glycine 20%
• Low Ionic Strength 20%
• Immunoelectrophoresis 20%
• Laparotomy 20%
• Response to Chemotherapy 20%
• Controlling Factors 20%
• Intra-arterial 20%
• Tumor Marker 20%
• Hemostasis 20%
• Fibrinopeptide A 20%
• Calcium Chloride 20%
• Clinical Improvement 20%
• Clinical Deterioration 20%
• Normally-off 20%
• Gastrointestinal Bleeding 20%
• Thrombin Clotting Time 20%
• High Ionic Strength Solutions 20%
• Factor Replacement 20%
• Plasma Fibrinogen 20%
• Factor 9 20%
• Clotting Factors 20%
• Hepatic Mass 20%
• Factor IX Deficiency 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Fibrinogen 100%
• Chemotherapy 100%
• Liver Cell Carcinoma 100%
• Dysfibrinogenemia 100%
• Fibrin Monomer 50%
• Monomer 33%
• Thrombin 33%
• Blood Clotting Factor 9 33%
• Wound Healing 16%
• Sepsis 16%
• Tumor Marker 16%
• Ionic Strength 16%
• Deterioration 16%
• Batroxobin 16%
• Clotting Time 16%
• Sialic Acid 16%
• Blood Stasis 16%
• Calcium Chloride 16%
• Blood Clotting Factor 16%
• Gastrointestinal Hemorrhage 16%
• Gel Electrophoresis 16%

Medicine and Dentistry

• Fibrinogen 100%
• Hepatocellular Carcinoma 100%
• Dysfibrinogenemia 100%
• Fibrin Monomer 50%
• Monomer 33%
• Sepsis 16%
• Gel Electrophoresis 16%
• Infusion 16%
• Wound Healing 16%
• Tumor Marker 16%
• Deterioration 16%
• Blood Stasis 16%
• Thrombin Time 16%
• Batroxobin 16%
• Thrombin 16%
• Sialic Acid 16%
• Laparotomy 16%
• Calcium Chloride 16%
• Gastrointestinal Bleeding 16%
• Blood Clotting Factor 16%